This inventor holds 1 USPTO granted patent. Top assignee: Pacesetter, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations by Larry Sloman in Cardiac Treatment Technologies
Introduction
Larry Sloman, an innovative inventor based in West Hollywood, CA, has made significant contributions to the field of cardiac treatment technologies. His work primarily focuses on methods and systems that improve the quality of life for heart failure patients through advanced stimulation devices.
Latest Patents
Larry Sloman holds a patent for "Implantable stimulation devices, and methods and systems for use therewith, that automatically adjust stimulation parameters to improve preload in a HF patient." This technology involves automatically adjusting cardiac resynchronization therapy (CRT) pacing parameters to reduce left ventricular diastolic pressure, thereby enhancing the condition of heart failure patients. The patent addresses how these systems can optimize patient outcomes more effectively than traditional acute hemodynamic optimization methods.
Career Highlights
Sloman's career includes pivotal roles in developing groundbreaking medical technologies. He has dedicated his efforts to ensuring that patients with heart failure experience better management of their condition. His innovative approach to cardiac stimulation has the potential to significantly improve patient outcomes and healthcare processes.
Collaborations
Throughout his career, Larry Sloman has collaborated with notable professionals in his field, including Edward Karst and Kritika Gupta. Working alongside such talented individuals has contributed to the advancements in cardiac technologies and the successful implementation of his patented systems.
Conclusion
Larry Sloman's work exemplifies the impact of innovation in the medical field, particularly for individuals suffering from heart failure. His patent not only highlights his contributions but also sheds light on the potential for future advancements in cardiac treatment technologies. As he continues his work at Pacesetter, Inc., his expertise and creativity are likely to drive further developments in this vital area of healthcare.